Strive Pharmacy
- 503A
“EdgeRx works with a single network of compounding pharmacies: Strive Pharmacy, a US-licensed 503A pharmacy compounding prescription medications since 2018.”
Source: edgerx.org · Verified 2026-08-04
EdgeRx Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.8/10
Best for: men wanting a physician-led peptide clinic, though its GLP-1 line isn't orderable yet
6.8
★★★☆☆3.4/5
EdgeRx stands out for its medical oversight and pharmacy verification.
Semaglutide
$229/mo
Tirzepatide
$299/mo
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
See plans →See plans at EdgeRx →
Compare top-rated alternatives ↓No insurance needed · Vetted by our editors
EdgeRx is a men's peptide and longevity telehealth platform from EdgeRx Health, LLC. Semaglutide and Tirzepatide injections, each formulated with muscle-preserving glycine and B12, sit alongside four other outcome categories (recovery, cognition, hair, sexual health) and are compounded by a single named 503A pharmacy, Strive Pharmacy. Protocols are cash-pay with HSA/FSA accepted through Truemed, and physician review is included in the price. As of this review, both GLP-1 injections are priced and described on the site but are waitlist-only — checkout is not yet live for any protocol.
By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
SemaglutideTirzepatideCompoundedLegitScript VerifiedHSA/FSA AcceptedFree ShippingBoard-Certified MDsMen's-Only Protocols
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to EdgeRx
6.2/ 10
Verified partnerWellorithm
Best for: compounded GLP-1 access with oral tablet options across 49 states
★★★☆☆3.1/5
Editorial score · methodology
$147/mosemaglutide
$247/motirzepatide
CompoundedSemaglutideTirzepatide
Get StartedRead full Wellorithm review →★★★★☆3.6/5
Editorial score · methodology
$139/mosemaglutide
$159/motirzepatide
CompoundedSemaglutideTirzepatideGHK-CuGlutathione
Get StartedRead full AgelessRx review →★★★★☆3.6/5
Editorial score · methodology
$299/mosemaglutide
$399/motirzepatide
CompoundedSemaglutideTirzepatide
Get StartedRead full Willow review →EdgeRx at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $229/mo
- What's included
- Medication · Consult · Shipping
- Availability
- 46 states
- FDA status
- No FDA warning letter on record
How we scored EdgeRx
Each dimension is scored algorithmically from EdgeRx’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
5.5/10At $229/mo, EdgeRx runs about 35% above the $170 median for GLP-1 providers.
Effectiveness25%
7.4/10EdgeRx offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
6.7/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
8.6/10Key details fully confirmed by our editors; no FDA warning letters on file; dispenses through an accredited compounding pharmacy; discloses which pharmacy makes its medication.
Accessibility10%
8.0/10EdgeRx treats patients in all 50 states. FSA/HSA cards are accepted.
Support10%
5.2/10EdgeRx provides standard clinician follow-up; no extended coaching or community program is disclosed.
6scored dimensions
607providers compared
100%verified against live provider sites
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this EdgeRx review
Last checked August 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Verified the compounding pharmacy partner and its accreditation
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: high.
What to expect when you sign up with EdgeRx
We walked EdgeRx’s public signup flow in August 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1On the 'Find Your Protocol' quiz, selected 'Metabolic & Body Composition' (Lose weight. Drop body fat. Preserve muscle.)
- 2Answered one goal question ('20+ pounds, the most effective GLP-1') and received a Tirzepatide Injection recommendation at $299/mo, shown before any health questions were asked
- 3Clicked 'Continue to Checkout' — the button did not advance; the Tirzepatide and Semaglutide protocol pages both state the protocol 'is not currently available for purchase' and instead offer a waitlist signup
- 4Tested the checkout URL directly for two in-stock-looking protocols (MICC Lipotropic Injection and Sermorelin Nasal Spray) — both display 'Checkout coming soon,' confirming the entire site's purchase flow is not yet live, not just the GLP-1 SKUs
Price shown before you start
- The GLP-1 line (semaglutide $229/mo, tirzepatide $299/mo) is fully priced and described but is waitlist-only — the quiz never reaches a working checkout for it
- Checkout is non-functional sitewide as tested: even products with an active 'Start Your Protocol' button land on a 'Checkout coming soon' page
- The quiz shows price before any health questions, and the site states the medical assessment happens 'post-checkout' — once checkout goes live, you'd pay before intake
- The site links directly to a LegitScript verification seal that resolves live (200 OK), and names its single pharmacy partner (Strive Pharmacy) up front — more transparent than many competitors
EdgeRx customer support
- info@edgerx.org
GLP-1 medications EdgeRx offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Once-weekly subcutaneous injection, variable-dose vials, titrated by physician. Not currently available for purchase — waitlist only as of Aug 2026.Compounded
$229/mo
semaglutide
Formulated with glycine + B12; compounded by Strive Pharmacy (503A). Protocol page states 'The Semaglutide protocol is not currently available for purchase.'
Once-weekly subcutaneous injection, variable-dose vials, titrated by physician. Not currently available for purchase — waitlist only as of Aug 2026.Compounded
$299/mo
tirzepatide
Formulated with glycine + B12; compounded by Strive Pharmacy (503A). Protocol page states 'The Tirzepatide protocol is not currently available for purchase.'
Ready to get started?
Plans and promotions change often — check EdgeRx's current pricing and active discounts before you decide.
EdgeRx compounding-pharmacy partners
Each partner below is a 503A or 503B pharmacy that EdgeRx routes prescriptions through. Each entry is anchored to a verbatim primary-source quote from the provider’s or pharmacy’s own site.
What we like
- Board-certified physicians prescribe every protocol, not a nurse-practitioner questionnaire
- Single named 503A pharmacy partner, Strive Pharmacy, compounding since 2018
- LegitScript seal independently verified live (returns 200 OK), a real certification
- GLP-1 doses formulated with glycine and B12 for muscle preservation and reduced nausea
- Free shipping on every order, including temperature-sensitive injectables
- HSA/FSA reimbursable through Truemed; transparent cash-pay pricing, no insurance games
- Cancel or pause anytime with no cancellation fee and no minimum commitment
- Refunded in full if a physician doesn't approve your protocol
Watch-outs
- Semaglutide and Tirzepatide are not currently available for purchase — waitlist only
- Checkout is 'coming soon' sitewide; no protocol on the entire site can currently be purchased
- You're charged before the medical assessment and physician review even happen
- MICC add-on price is inconsistent on EdgeRx's own site: $49/mo on protocol pages vs. $79/mo in the category FAQ
- Not available in Arkansas, Indiana, Minnesota, or South Carolina
- No published support phone number or stated customer-service hours — email only
- Binding arbitration and class-action waiver in the Terms of Service
- Men's-only branding and formulations — not an option for women
Is EdgeRx worth it? Our verdict
EdgeRx positions itself around one thing: men wanting a physician-led peptide clinic, though its GLP-1 line isn't orderable yet. It runs $229/month — a premium to the category, so the extras need to justify it. It treats patients in all 50 states, so access isn't a barrier.
Where EdgeRx tries to set itself apart is the extras: LegitScript Verified, HSA/FSA Accepted, and Board-Certified MDs.
How much EdgeRx actually costs
- Compounded semaglutide — $229/month
- Compounded tirzepatide — $299/month
For context, the typical ongoing price across the GLP-1 providers we track is around $170/month, so EdgeRx's standing rate sits at the premium end.
For a direct comparison, MadeMed runs semaglutide and tirzepatide from $219/month — worth pricing against EdgeRx before you commit.
Medications: what EdgeRx prescribes
EdgeRx prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products — the standard trade-off across the compounded-GLP-1 market.
Who EdgeRx is best for — and who should skip it
A good fit if you…
- live anywhere in the US and want guaranteed access.
Look elsewhere if you…
- want the lowest total cost over 6–12 months — a flat-rate provider like Collective will likely beat the ongoing price.
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
EdgeRx treats patients in all 50 states, dispenses through an accredited compounding pharmacy, and names the pharmacy that fills its prescriptions. We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
EdgeRx costs more than the budget end of the market, so it makes the most sense if its specific extras matter to you. If they don't, you can likely get the same medication for less elsewhere.
The Bottom Line
EdgeRx stands out for its medical oversight and pharmacy verification.
Score: 6.8/10Best for: men wanting a physician-led peptide clinic, though its GLP-1 line isn't orderable yetFrom: $229/mo
Ready to start with EdgeRx?
Starting at $229/month. See current pricing and start your free consultation.
EdgeRx might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Collective (from $59/mo).
- If you want built-in coaching and behavior-change support, consider Fella Health.
Frequently Asked Questions
EdgeRx is a men's peptide and longevity telehealth platform from EdgeRx Health, LLC. Semaglutide and Tirzepatide injections, each formulated with muscle-preserving glycine and B12, sit alongside four other outcome categories (recovery, cognition, hair, sexual health) and are compounded by a single named 503A pharmacy, Strive Pharmacy. Protocols are cash-pay with HSA/FSA accepted through Truemed, and physician review is included in the price. As of this review, both GLP-1 injections are priced and described on the site but are waitlist-only — checkout is not yet live for any protocol. We scored it 6.8/10 across our six-dimension editorial framework.
Yes — EdgeRx is a legitimate telehealth provider. Our editors independently verified its pricing and offering and scored it 6.8/10 across our six-dimension framework, and it discloses accredited (503A/503B/PCAB) compounding. As with any medication, consult a licensed clinician before starting.
EdgeRx starts at $229/month. See the pricing table above for every tier.
EdgeRx doesn't use public promo or coupon codes — its $229/month is an all-inclusive cash price with no insurance or coupons needed. Third-party sites advertising "EdgeRx discount codes" are typically fake; any current offer applies automatically through the link on this page.
EdgeRx treats patients in all 50 states.
EdgeRx offers semaglutide (the active drug in Wegovy/Ozempic) and tirzepatide (the active drug in Zepbound/Mounjaro). These are dispensed as compounded formulations.
EdgeRx dispenses compounded GLP-1s made by a licensed compounding pharmacy — the same active ingredient as the brand drugs at a lower cash price. Compounded drugs are not FDA-approved as finished products; we cover what that means in the review.
EdgeRx is a cash-pay program (no insurance required) and accepts FSA/HSA cards.
EdgeRx's price includes medication, the clinician consult and shipping. See the "what's included" strip near the top of this review.
You complete an online intake, a licensed clinician reviews whether a GLP-1 is appropriate for you, and — if approved — your medication ships to your door. You can begin the consultation directly on EdgeRx's site.
We don't find any safety warnings on file (no FDA action). The concerns our review flags are mostly transparency-related: Semaglutide and Tirzepatide are not currently available for purchase — waitlist only; Checkout is 'coming soon' sitewide; no protocol on the entire site can currently be purchased; You're charged before the medical assessment and physician review even happen; MICC add-on price is inconsistent on EdgeRx's own site: $49/mo on protocol pages vs. $79/mo in the category FAQ. None are safety issues, but they're worth weighing before you sign up.
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this EdgeRx review:
Sources & methodology — as of September 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See EdgeRx's current pricing
Plans start at $229/month. Start your free consultation to check eligibility and today's price.
Not sold on EdgeRx?
Vetted alternatives